When a New Drug is Costly, Not Approved, and Possibly Life Changing
When a New Drug Is Costly, Not Approved and Possibly Life Changing A trial cystic fibrosis treatment could offer a ‘new normal’ for people like Lilia Zaharieva. But they risk hopes dashed. Emily Fagan is a Victoria-based freelance journalist passionate about reporting on social issues. You can find her work in Vice, the CBC and Ricochet, or follow her on Twitter @thatemfagan. SHARES The arrival of a new treatment for cystic fibrosis, Trikafta, is being lauded as a welcome development for people like Lilia Zaharieva. But access to the potentially life-saving dr...
Source: thetyee.ca